- Boomers
- |
- Nov 07, 2020
Vivek Ramaswamy Quotes
Most Famous Vivek Ramaswamy Quotes of All Time!
We have created a collection of some of the best vivek-ramaswamy quotes so you can read and share anytime with your friends and family. Share our Top 10 Vivek Ramaswamy Quotes on Facebook, Twitter, and Pinterest.
- Last Updated on May 30, 2021
- Amazing Things
- |
- Nov 07, 2020
It's a great disappointment as a leader in the biotech industry that with all the amazing things the drug industry has done in the last couple of decades, we have not made a single major advance, have not not developed a single new chemical entity approved for the treatment for Alzheimer's disease.
- Difference
- |
- Nov 07, 2020
I take a lot of personal pride and motivation to be able to make a difference in areas that may fall through the cracks in R&D across the industry.
- Every Day
- |
- Nov 07, 2020
In contrast to how tech firms want to disrupt and break things - developing drugs must be incremental and step-by-step. This is the kind of work that involves people putting their lives on the line every day with clinical trials.
- Me
- |
- Nov 07, 2020
The more general skepticism about another millennial that likes to claim they're disrupting another industry - that doesn't serve me well.
- Consulting
- |
- Nov 07, 2020
I'd encourage more young people to apply their talents beyond finance and consulting and to think about reshaping how medicines are brought to market and how the business is run.
- Believe
- |
- Nov 07, 2020
This may sound trite, but I believe it to be true: Entrepreneurship is the fabric of what America is all about.
- Desire
- |
- Nov 07, 2020
I would think the correlation between an era of increased globalization and an increased desire to participate in an entrepreneurial endeavor is not a coincidence. When interconnectedness is at a peak due to technological advances, the ability to spawn something new is slightly easier.
- Myself
- |
- Nov 07, 2020
From a personal standpoint, I consider myself much more of an accidental entrepreneur. I was involved in the entrepreneurship club at Harvard, but I heard of it only because it was new on campus.
- Down
- |
- Nov 07, 2020
There is probably a promising drug candidate that has already been discovered for the treatment of Down syndrome that is sitting on the shelf of some drug company.
- Others
- |
- Nov 07, 2020
For some companies, going public makes the most sense. For others, remaining private is preferable.
- Need
- |
- Nov 07, 2020
If we can validate our scientific bets in the clinic, if we can bring valuable new treatments to patients that need them, that will be our ultimate measure of success.
- Development
- |
- Nov 07, 2020
I really was inspired by the possibility of more directly being involved in the development of drugs myself.
- Future
- |
- Nov 07, 2020
I've said all along that we're building Axovant as a lasting company for the long run, not to hand over that upside to a pharma company in the future.
- Light
- |
- Nov 07, 2020
The problem we are trying to solve is that of drugs that would have never seen the light of day for reasons that have nothing to do with the inherent properties of drug candidates themselves and more to do with bureaucratic institutions within which they often sit.
- Disease
- |
- Nov 07, 2020
I would not have had the same personal commitment to Alzheimer's disease if it had not been for my mother and my upbringing.
- Need
- |
- Nov 07, 2020
I can't comment on the internal decision-making at other companies, but RVT-101 has the potential to be a very valuable product in the treatment of Alzheimer's, which is a huge unmet medical need.
- Disease
- |
- Nov 07, 2020
Our goal is to continue to build the pipeline to fight all aspects of disease for all forms of dementia.
- End
- |
- Nov 07, 2020
There is no doubt that the Mindset failure is a major setback for Axovant, but it is not the end of the road.
- People
- |
- Nov 07, 2020
The most important ingredient for the success of any company is the quality of its people, starting with its leadership team.
- More
- |
- Nov 07, 2020
Roivant does not view - and has never viewed - Axovant as simply a 'vehicle' for developing intepirdine, but instead as a platform for the development of high-impact drugs in dementia and the neuroscience field more generally.
- Growth
- |
- Nov 07, 2020